RI Bio (EIN 462858053) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

Glenn Robertelli

Phone

4014005499

Tax Period

2023-01-01 to 2023-12-31

RI Bio, founded in 2013, is a small nonprofit in the Medical Research sector that reported $661K in total revenue in fiscal year 2023.

Mission

RI Bio's mission is to serve as a catalyst for biotech industry acceleration, advocating for better policy, educating a strong life science workforce, collaborating with life sciences companies, hospitals, universities, capital sources and government agencies, sharing information and expertise, and promoting the advancement of science.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $513,430

Program Service Revenue $147,926

Investment Income $0

Other Revenue $32

TOTAL REVENUE $661,388

Expense Breakdown

Grants Paid $0

Salaries & Benefits $159,454

Fundraising Expenses $9,975

Program Expenses $611,216

Other Expenses $512,159

TOTAL EXPENSES $671,613

Year-over-Year Comparison

	2023	2022	Change
Revenue	$661,388	$686,804	0.0%
Expenses	$671,613	$697,430	0.0%
Net Income	$-10,225	$-10,626	0.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$145,710

Total Directors

$145,710

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Margaret Farrell	Secretary	1.00	Officer Director	$0	$0	$0
Michael Katz	Director	1.00	Director	$0	$0	$0
Patrice Milos	Director	1.00	Director	$0	$0	$0
Michael Elliott	Director	1.00	Director	$0	$0	$0
Guy Asadorian	Director	1.00	Director	$0	$0	$0
Dom Messerli	Director	1.00	Director	$0	$0	$0
Carol Malysz	President	40.00	Officer Director	$145,710	$0	$145,710

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$661,388	$671,613	$98,004	$-10,225
2022	$686,804	$697,430	$119,673	$-10,626
2021	$212,321	$217,214	$97,456	$-4,893
2021	$446,723	$384,386	$228,555	$62,337
2020	$452,799	$456,359	$60,944	$-3,560
2018	$296,159	$273,969	$47,627	$22,190

RI Bio